Which sections of the Body20 Franchise Agreement are amended by the Rider?

According to the 2025 Body20 Franchise Disclosure Document, the Rider to the Franchise Agreement amends specific sections depending on the franchisee's location. For franchisees in Maryland, the Rider adds a provision to the end of Sections 2.2(d) ("Successor Term"), 13.4(d) ("Control Transfer"), 13.5 ("Non-Control Transfers"), 13.6 ("Transfer To an Entity"), and 15.7(d) ("Closing") of the Franchise Agreement. This addition stipulates that the general release required as a condition of renewal, sale, and/or assignment/transfer will not apply to any liability arising under the Maryland Franchise Registration and Disclosure Law. This ensures that Body20 franchisees in Maryland retain their rights under Maryland franchise law, even when signing a general release.

For franchisees in Rhode Island, the Rider modifies Section 16.1 of the Franchise Agreement by adding that Rhode Island law will apply to claims arising under the Rhode Island Franchise Investment Act to the extent required by applicable law. Additionally, the Rider adds language to the end of Section 16.3(d) of the Franchise Agreement concerning consent to jurisdiction.

For franchisees in North Dakota, Section 16.4 of the Franchise Agreement, regarding waiver of jury trial, is deleted, but only to the extent required by the North Dakota Franchise Investment Law. These state-specific amendments are crucial for Body20 franchisees to understand their rights and obligations under the laws of their respective states, as they take precedence over the standard terms of the Franchise Agreement.